MedMira Inc. (FRA:47M)

Germany flag Germany · Delayed Price · Currency is EUR
0.0310
-0.0025 (-7.46%)
At close: Dec 4, 2025
-33.33%
Market Cap 28.05M
Revenue (ttm) 151.92K
Net Income (ttm) -2.86M
Shares Out n/a
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 676
Open 0.0420
Previous Close 0.0335
Day's Range 0.0285 - 0.0420
52-Week Range 0.0285 - 0.0775
Beta n/a
RSI 35.71
Earnings Date Nov 28, 2025

About MedMira

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV ... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1993
Employees 52
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 47M
Full Company Profile

Financial Performance

In 2025, MedMira's revenue was 240,509, a decrease of -41.70% compared to the previous year's 412,568. Losses were -4.52 million, 36.0% more than in 2024.

Financial numbers in CAD Financial Statements

News

There is no news available yet.